1. The University of British Columbia Centre for Heart Lung Innovation, St. Paul’s Hospital, Vancouver, British Columbia, Canada
2. Department of Molecular Medicine
3. Institut Universitaire de Cardiologie et de Pneumologie de Québec, and
4. Department of Molecular Biology, Medical Biochemistry, and Pathology, Laval University, Québec, Quebec, Canada
5. Merck Research Laboratories, Genetics and Pharmacogenomics, Boston, Massachusetts
6. Icahn Institute of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, New York
7. Department of Pulmonology, and
8. Department of Pathology and Medical Biology, GRIAC Research Institute, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
9. Prevention of Organ Failure (PROOF) Centre of Excellence, Vancouver, British Columbia, Canada
10. GlaxoSmithKline, King of Prussia, Pennsylvania
11. Division of Pulmonary and Critical Care Medicine, University of Nebraska Medical Center, Omaha, Nebraska
12. Clinical Discovery Unit, Early Clinical Development, AstraZeneca, Cambridge, United Kingdom
13. Division of Computational Biomedicine, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts
14. Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada
15. Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada
16. Fundacio Clinic per a la Recerca Biomedica, Barcelona, Spain
17. Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada; and
18. Respiratory Division, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada